Skip to main content
Celltrion Pharm Inc. logo

Celltrion Pharm Inc. — Investor Relations & Filings

Ticker · 068760 ISIN · KR7068760008 KO Manufacturing
Open in API
Filings indexed 336 across all filing types
Latest filing 2021-12-17 Notice of Dividend Amou…
Country KR South Korea
Listing KO 068760

About Celltrion Pharm Inc.

https://www.celltrionph.com/en-us/home/…

Celltrion Pharm Inc. is a pharmaceutical company specializing in the manufacturing and supply of chemical pharmaceuticals and biosimilar products. The company's portfolio includes treatments for various conditions, with a notable focus on biosimilars for autoimmune diseases. A key product is Remsima, a biosimilar of Infliximab, indicated for treating rheumatoid arthritis, Crohn's disease, ulcerative colitis, and psoriasis. As an integral part of the global biopharmaceutical company Celltrion, Celltrion Pharm distributes its products to both domestic and international markets, contributing to the accessibility of advanced biologic therapies.

Recent filings

Filing Released Lang Actions
주식배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Celltrion Pharm regarding a 'Stock Dividend Decision' (주식배당결정). It specifies the number of shares per dividend, the total number of shares to be issued, the record date, and the board resolution date. This falls under the category of dividend announcements, which is classified as DIV.
2021-12-17 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure period for the purpose of holding an Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal regulatory notice of the upcoming meeting logistics. Given it is a standard regulatory announcement regarding corporate governance procedures, it fits best under the RNS category.
2021-12-16 Korean
대규모기업집단현황공시[분기별공시(개별회사용)]
Audit Report / Information Classification · 95% confidence The document is a 'Corporate Group Status Disclosure' (기업집단현황공시) filed by Celltrion Pharm. This is a mandatory regulatory filing in South Korea required by the Fair Trade Commission to disclose information about large business groups, including shareholding structures, inter-company transactions, and financial status. Since it is a specific regulatory disclosure document that does not fit into financial reporting (10-K/IR) or other specific categories like M&A or dividends, it falls under the 'Regulatory Filings' (RNS) category. Q1 2024
2021-11-30 Korean
분기보고서 (2021.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Celltrion Pharm, Inc. covering the period from January 1, 2021, to September 30, 2021. It contains detailed financial data, business operations, and management information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2021
2021-11-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a standard regulatory disclosure for insider trading or changes in share ownership by company directors and executives. According to the provided definitions, this falls under 'Director's Dealing' (DIRS).
2021-11-04 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. This type of filing is a mandatory disclosure by company insiders (directors/executives) regarding their personal share transactions or changes in ownership. According to the provided definitions, this corresponds to 'Director's Dealing' (DIRS).
2021-11-04 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.